TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway

被引：0
|
作者：
Yanqing Ye
Maosheng Liu
Fengfei Wu
Shiyu Ou
Weidong Wang
Jieying Fei
Fang Xie
Lan Bai
机构：
[1] Southern Medical University,Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital
[2] The First Affiliated Hospital of Gannan Medical University,Department of Gastroenterology
[3] The Fourth Affiliated Hospital of Guangxi Medical University,Department of Gastroenterology
来源：
European Journal of Medical Research | / 28卷
关键词：
Hepatocellular carcinoma; Cell proliferation; TRMT6; PI3K/AKT; mTOR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
    Zhangya Pu
    Dan G. Duda
    Yuanyuan Zhu
    Siya Pei
    Xiaofang Wang
    Yan Huang
    Panpan Yi
    Zebing Huang
    Fang Peng
    Xingwang Hu
    Xuegong Fan
    [J]. Journal of Translational Medicine, 20
  • [42] CEMIP promotes ovarian cancer development and progression via the PI3K/AKT signaling pathway
    Shen, Fan
    Zong, Zhi-hong
    Liu, Yao
    Chen, Shuo
    Sheng, Xiu-jie
    Zhao, Yang
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [43] TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway
    Huang, Tao
    Chen, Qi-Feng
    Chang, Bo-Yang
    Shen, Lu-Jun
    Li, Wang
    Wu, Pei-Hong
    Fan, Wei-Jun
    [J]. DISEASE MARKERS, 2019, 2019
  • [44] RETRACTION: MicroRNA-367 promotes progression of hepatocellular carcinoma through PTEN/PI3K/AKT signaling pathway (Retraction of art no BSR20182466, 2019)
    Wang, Zihua
    Luo, Yu
    [J]. BIOSCIENCE REPORTS, 2020, 40
  • [45] The role of PI3K/AKT signaling pathway in gallbladder carcinoma
    Wu, Zeyu
    Yu, Xiao
    Zhang, Shuijun
    He, Yuting
    Guo, Wenzhi
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (07): : 4426 - 4442
  • [46] STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K/Akt pathway
    Wu, J-Z
    Jiang, N.
    Lin, J-M
    Liu, X.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (06) : 2977 - 2985
  • [47] PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway
    Zhao, Gang
    Shi, Xiaobao
    Sun, Zhanbo
    Zhao, Pengfei
    Lu, Zaiming
    [J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53 (12) : 1602 - 1613
  • [48] Statins interfere on TCTP and PI3K/AKT/mTOR pathway and inhibit hepatocellular carcinoma progression
    Garcia-Valdecasas, Marta
    Gil-Gomez, Antonio
    Rojas, Angela
    Muntane, Jordi
    PAdillo Ruiz, Farncisco Javier
    Romero-Gomez, Manuel
    Antonio Del Campo, Jose
    [J]. HEPATOLOGY, 2014, 60 : 653A - 653A
  • [49] LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway
    Zheng, Yong-Fa
    Zhang, Xiao-Yu
    Bu, Yan-Zhi
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 4172 - 4179
  • [50] TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway
    Zhang, L-H
    Yin, A-A
    Cheng, J-X
    Huang, H-Y
    Li, X-M
    Zhang, Y-Q
    Han, N.
    Zhang, X.
    [J]. ONCOGENE, 2015, 34 (05) : 600 - 610
12345